Fakeeh Careفقيه الطبية
- Price
- 38.46 SAR
- Fair value
- 11.85 SAR
- Discount to fair value
- −225%
- Mkt cap
- 8.92B
- P/E
- 30.7×
- P/B
- 2.81×
- EV
- 9.66B
- Div yield
- 0.77%
- ROE
- 9.1%
- Net margin
- 9.4%
Current price38.46SAR
Fair value (est., median)11.85SAR
UndervaluedFair valueOvervalued
+224.6% above fair valueWould need to fall ~69.2% to reach fair value.
Median ofGraham 19.56Residual Income 11.12Earnings Power 11.85
Health Check
38
Overall / 100
Good (66+)Caution (40–65)Risk (<40)
Rewards
—
Risks
- Trades 224.6% above estimated fair value.
- Low fair-value confidence — methods disagree or data is thin.
Scores are computed automatically from the real financial statements (Value from fair value; the rest from growth, profitability, balance sheet and dividends). A decision aid, not investment advice.
Price, corporate actions & news
Demo series
D — DividendS — Split▲ good · ▼ bad newstap a marker for detailsDemo series
Growth & profitability
Revenue, net income and margin.
RevenueNet incomeNet margin %tap a bar for figures
Key figures
Covers 3 years · FY2023–FY2025
| Metric | FY'23 | FY'24 | FY'25 | TTM'26 |
|---|---|---|---|---|
| Revenue | 2.33B | 2.79B | 3.09B | — |
| Net Income | 279.60M | 287.55M | 290.18M | 227.90M |
| Net Margin | 12.0% | 10.3% | 9.4% | — |
| Operating Cash Flow | 228.63M | 436.10M | 453.91M | — |
| OCF Margin | 9.8% | 15.6% | 14.7% | — |
| Capital Expenditure | 376.51M | 524.85M | 529.41M | — |
| Free Cash Flow | -147.89M | -88.75M | -75.50M | — |
| FCF Margin | -6.4% | -3.2% | -2.4% | — |
| FCF Conversion | -52.9% | -30.9% | -26.0% | — |
| EPS (Diluted) | 1.21/sh | 1.24/sh | 1.25/sh | 0.98/sh |
| Dividend / Share | 4.96/sh | — | 0.30/sh | — |
Dividend return (if you buy today)if you buy today
Dividend yield0.77%
Dividend / share0.30
If you invest
Shares (≈)260
Est. annual income77.32
At this rate, dividends alone return your capital in ~129.3 years.
Dividend history
Dividend / share & historical yield (SAR).
Dividend / share yield %tap a bar for figures
Quarterly dividends & yield
Per-share dividends by quarter, full-year total, and yield on the year's average price · SAR
| Year | Q1 | Q2 | Q3 | Q4 | Full year | Yield (avg) |
|---|---|---|---|---|---|---|
| 2026 | — | — | — | — | — | — |
| 2025 | — | — | — | — | 0.30 | — |
| 2024 | — | — | — | — | — | — |
| 2023 | — | — | — | — | 4.96 | — |
Valuation breakdown
Fair value = median of the applicable methods (Graham، Residual Income، Earnings Power).
Each method below is a different lens on the same company — no single method dominates the result.
Discounted Cash Flow
Excluded — non-positive free cash flow
N/A
Dividend Discount Model
Values the share from the dividends it's expected to keep paying. · Tap to adjust assumptions
4.46
Graham Number
A conservative benchmark built from earnings and book value. · Tap to adjust assumptions
19.56
Residual Income (justified P/B)
Values the profit the company earns above the cost of its equity. · Tap to adjust assumptions
11.12
Earnings Power Value
Values today's earning power as-is, assuming no growth. · Tap to adjust assumptions
11.85
DCF only is anchored on FY2025 — the latest year with positive cash flow that supports a value. The other methods (DDM, Graham, RIM, EPV) use current / normalized figures.
Fair Value (median)11.85
▸ Show assumptions▾ Assumptions
- Effective discount rate
- 9.87%
- CAPM cost of equity
- 10.50%
- Risk-free rate
- 4.50%
- Equity risk premium
- 6.00%
- DCF growth (stage 1)
- 8.00%
- DCF terminal growth
- 3.00%
- DCF forecast years
- 5
- DDM dividend growth
- 3.00%
Tune these per company in the Hajras Odoo backend; values recompute automatically.
Wealth simulator
What if you'd invested in Fakeeh Care regularly?
Starting year
- Invested
- 1K/yr · 1K total(2026 → today · 1 yrs)
- your value today is
- 1K SAR
- Total return
- +0.8%(+0.8% Dividends · 0.0% Capital gain)
- Annualised (IRR)
- +1.7%
Invested1KSAR
Dividends8SAR
Capital gain0SAR
InvestedCapital gainDividendstap a bar for figures
Community Notes0
No notes yet. Be the first to share a thesis.